Oliver Politz
4PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 26, 2023
A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies.Sabine Zitzmann-Kolbe, Alexander Kristian, Dieter Zopf
|Feb 11, 2023
Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment.Fabio Raith, Daniel H O'Donovan, Clara Lemos
|May 07, 2020
Preclinical Activity of PI3K Inhibitor Copanlisib in Gastrointestinal Stromal Tumor.Alfonso García-Valverde, Jordi Rosell, Garazi Serna
|Feb 27, 2019
Rogaratinib: A potent and selective pan-FGFR inhibitor with broad antitumor activity in FGFR-overexpressing preclinical cancer models.Sylvia Grünewald, Oliver Politz, Sebastian Bender
Pageof 1
Frequent Collaborators
1 joint publications
Garazi Serna
1 joint publications
Paolo Nuciforo
1 joint publications
Joaquín Arribas
1 joint publications
Fabio Raith
1 joint publications
Clara Lemos
1 joint publications
Bernard Haendler
1 joint publications
Sabine Zitzmann-Kolbe
1 joint publications
Alexander Kristian
1 joint publications
Dieter Zopf
1 joint publications
Claudia Kamfenkel
